nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.131	0.148	CbGbCtD
Cabazitaxel—ABCG2—Sulfasalazine—ankylosing spondylitis	0.104	0.118	CbGbCtD
Cabazitaxel—SLCO1B3—Methotrexate—ankylosing spondylitis	0.0903	0.102	CbGbCtD
Cabazitaxel—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0577	0.0653	CbGbCtD
Cabazitaxel—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0526	0.0595	CbGbCtD
Cabazitaxel—ABCG2—Dexamethasone—ankylosing spondylitis	0.052	0.0589	CbGbCtD
Cabazitaxel—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0496	0.0561	CbGbCtD
Cabazitaxel—ABCG2—Methotrexate—ankylosing spondylitis	0.0418	0.0473	CbGbCtD
Cabazitaxel—ABCB1—Betamethasone—ankylosing spondylitis	0.0322	0.0365	CbGbCtD
Cabazitaxel—ABCB1—Prednisolone—ankylosing spondylitis	0.0318	0.036	CbGbCtD
Cabazitaxel—ABCB1—Prednisone—ankylosing spondylitis	0.03	0.034	CbGbCtD
Cabazitaxel—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0297	0.0336	CbGbCtD
Cabazitaxel—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0288	0.0326	CbGbCtD
Cabazitaxel—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0277	0.0313	CbGbCtD
Cabazitaxel—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0225	0.0255	CbGbCtD
Cabazitaxel—CYP3A4—Betamethasone—ankylosing spondylitis	0.0193	0.0219	CbGbCtD
Cabazitaxel—CYP3A4—Prednisolone—ankylosing spondylitis	0.0191	0.0216	CbGbCtD
Cabazitaxel—ABCB1—Dexamethasone—ankylosing spondylitis	0.0187	0.0212	CbGbCtD
Cabazitaxel—CYP3A4—Prednisone—ankylosing spondylitis	0.018	0.0204	CbGbCtD
Cabazitaxel—ABCB1—Methotrexate—ankylosing spondylitis	0.0151	0.0171	CbGbCtD
Cabazitaxel—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0112	0.0127	CbGbCtD
Cabazitaxel—Erythema—Triamcinolone—ankylosing spondylitis	0.000381	0.00335	CcSEcCtD
Cabazitaxel—Erythema—Methylprednisolone—ankylosing spondylitis	0.00038	0.00334	CcSEcCtD
Cabazitaxel—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00038	0.00334	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000377	0.00332	CcSEcCtD
Cabazitaxel—Breast disorder—Methotrexate—ankylosing spondylitis	0.000377	0.00332	CcSEcCtD
Cabazitaxel—Malaise—Prednisolone—ankylosing spondylitis	0.000373	0.00328	CcSEcCtD
Cabazitaxel—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000373	0.00328	CcSEcCtD
Cabazitaxel—Vertigo—Prednisolone—ankylosing spondylitis	0.000372	0.00327	CcSEcCtD
Cabazitaxel—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000371	0.00326	CcSEcCtD
Cabazitaxel—Eye disorder—Betamethasone—ankylosing spondylitis	0.000371	0.00326	CcSEcCtD
Cabazitaxel—Back pain—Triamcinolone—ankylosing spondylitis	0.000368	0.00324	CcSEcCtD
Cabazitaxel—Angiopathy—Betamethasone—ankylosing spondylitis	0.00036	0.00317	CcSEcCtD
Cabazitaxel—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00036	0.00317	CcSEcCtD
Cabazitaxel—Hypertension—Prednisolone—ankylosing spondylitis	0.000357	0.00314	CcSEcCtD
Cabazitaxel—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000354	0.00312	CcSEcCtD
Cabazitaxel—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000354	0.00312	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000353	0.00311	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000352	0.0031	CcSEcCtD
Cabazitaxel—Alopecia—Betamethasone—ankylosing spondylitis	0.00035	0.00308	CcSEcCtD
Cabazitaxel—Alopecia—Dexamethasone—ankylosing spondylitis	0.00035	0.00308	CcSEcCtD
Cabazitaxel—Discomfort—Prednisolone—ankylosing spondylitis	0.000348	0.00306	CcSEcCtD
Cabazitaxel—Erythema—Betamethasone—ankylosing spondylitis	0.000345	0.00304	CcSEcCtD
Cabazitaxel—Erythema—Dexamethasone—ankylosing spondylitis	0.000345	0.00304	CcSEcCtD
Cabazitaxel—Malaise—Triamcinolone—ankylosing spondylitis	0.000343	0.00302	CcSEcCtD
Cabazitaxel—Malaise—Methylprednisolone—ankylosing spondylitis	0.000342	0.00301	CcSEcCtD
Cabazitaxel—Vertigo—Triamcinolone—ankylosing spondylitis	0.000342	0.00301	CcSEcCtD
Cabazitaxel—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000341	0.003	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000339	0.00299	CcSEcCtD
Cabazitaxel—Oedema—Prednisolone—ankylosing spondylitis	0.000338	0.00297	CcSEcCtD
Cabazitaxel—Neutropenia—Methotrexate—ankylosing spondylitis	0.000337	0.00297	CcSEcCtD
Cabazitaxel—Dysuria—Methotrexate—ankylosing spondylitis	0.000337	0.00297	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000335	0.00295	CcSEcCtD
Cabazitaxel—Cough—Triamcinolone—ankylosing spondylitis	0.000332	0.00292	CcSEcCtD
Cabazitaxel—Tachycardia—Prednisolone—ankylosing spondylitis	0.00033	0.0029	CcSEcCtD
Cabazitaxel—Hypertension—Triamcinolone—ankylosing spondylitis	0.000329	0.00289	CcSEcCtD
Cabazitaxel—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000328	0.00288	CcSEcCtD
Cabazitaxel—Myalgia—Triamcinolone—ankylosing spondylitis	0.000324	0.00285	CcSEcCtD
Cabazitaxel—Pneumonia—Methotrexate—ankylosing spondylitis	0.000323	0.00284	CcSEcCtD
Cabazitaxel—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000323	0.00284	CcSEcCtD
Cabazitaxel—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000323	0.00284	CcSEcCtD
Cabazitaxel—Eye disorder—Prednisone—ankylosing spondylitis	0.000323	0.00284	CcSEcCtD
Cabazitaxel—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000322	0.00283	CcSEcCtD
Cabazitaxel—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000322	0.00283	CcSEcCtD
Cabazitaxel—Infestation—Methotrexate—ankylosing spondylitis	0.000322	0.00283	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000321	0.00282	CcSEcCtD
Cabazitaxel—Flushing—Prednisone—ankylosing spondylitis	0.000321	0.00282	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00032	0.00282	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00032	0.00282	CcSEcCtD
Cabazitaxel—Discomfort—Triamcinolone—ankylosing spondylitis	0.00032	0.00282	CcSEcCtD
Cabazitaxel—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000319	0.00281	CcSEcCtD
Cabazitaxel—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000317	0.00279	CcSEcCtD
Cabazitaxel—Renal failure—Methotrexate—ankylosing spondylitis	0.000316	0.00278	CcSEcCtD
Cabazitaxel—Angiopathy—Prednisone—ankylosing spondylitis	0.000313	0.00276	CcSEcCtD
Cabazitaxel—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000313	0.00275	CcSEcCtD
Cabazitaxel—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000312	0.00275	CcSEcCtD
Cabazitaxel—Immune system disorder—Prednisone—ankylosing spondylitis	0.000312	0.00274	CcSEcCtD
Cabazitaxel—Malaise—Betamethasone—ankylosing spondylitis	0.000311	0.00274	CcSEcCtD
Cabazitaxel—Malaise—Dexamethasone—ankylosing spondylitis	0.000311	0.00274	CcSEcCtD
Cabazitaxel—Oedema—Triamcinolone—ankylosing spondylitis	0.000311	0.00273	CcSEcCtD
Cabazitaxel—Vertigo—Dexamethasone—ankylosing spondylitis	0.00031	0.00273	CcSEcCtD
Cabazitaxel—Vertigo—Betamethasone—ankylosing spondylitis	0.00031	0.00273	CcSEcCtD
Cabazitaxel—Arrhythmia—Prednisone—ankylosing spondylitis	0.000309	0.00271	CcSEcCtD
Cabazitaxel—Infection—Triamcinolone—ankylosing spondylitis	0.000309	0.00271	CcSEcCtD
Cabazitaxel—Infection—Methylprednisolone—ankylosing spondylitis	0.000308	0.00271	CcSEcCtD
Cabazitaxel—Haematuria—Methotrexate—ankylosing spondylitis	0.000307	0.0027	CcSEcCtD
Cabazitaxel—Alopecia—Prednisone—ankylosing spondylitis	0.000305	0.00268	CcSEcCtD
Cabazitaxel—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000304	0.00267	CcSEcCtD
Cabazitaxel—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000303	0.00267	CcSEcCtD
Cabazitaxel—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000303	0.00267	CcSEcCtD
Cabazitaxel—Mental disorder—Prednisone—ankylosing spondylitis	0.000303	0.00266	CcSEcCtD
Cabazitaxel—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000302	0.00266	CcSEcCtD
Cabazitaxel—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000301	0.00265	CcSEcCtD
Cabazitaxel—Malnutrition—Prednisone—ankylosing spondylitis	0.000301	0.00264	CcSEcCtD
Cabazitaxel—Erythema—Prednisone—ankylosing spondylitis	0.000301	0.00264	CcSEcCtD
Cabazitaxel—Hypertension—Dexamethasone—ankylosing spondylitis	0.000298	0.00262	CcSEcCtD
Cabazitaxel—Hypertension—Betamethasone—ankylosing spondylitis	0.000298	0.00262	CcSEcCtD
Cabazitaxel—Myalgia—Betamethasone—ankylosing spondylitis	0.000294	0.00259	CcSEcCtD
Cabazitaxel—Myalgia—Dexamethasone—ankylosing spondylitis	0.000294	0.00259	CcSEcCtD
Cabazitaxel—Anxiety—Dexamethasone—ankylosing spondylitis	0.000293	0.00258	CcSEcCtD
Cabazitaxel—Anxiety—Betamethasone—ankylosing spondylitis	0.000293	0.00258	CcSEcCtD
Cabazitaxel—Discomfort—Dexamethasone—ankylosing spondylitis	0.00029	0.00255	CcSEcCtD
Cabazitaxel—Discomfort—Betamethasone—ankylosing spondylitis	0.00029	0.00255	CcSEcCtD
Cabazitaxel—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00029	0.00255	CcSEcCtD
Cabazitaxel—Pain—Prednisolone—ankylosing spondylitis	0.000289	0.00254	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000285	0.00251	CcSEcCtD
Cabazitaxel—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000283	0.00249	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000283	0.00249	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000282	0.00248	CcSEcCtD
Cabazitaxel—Oedema—Dexamethasone—ankylosing spondylitis	0.000282	0.00248	CcSEcCtD
Cabazitaxel—Oedema—Betamethasone—ankylosing spondylitis	0.000282	0.00248	CcSEcCtD
Cabazitaxel—Infection—Betamethasone—ankylosing spondylitis	0.00028	0.00246	CcSEcCtD
Cabazitaxel—Infection—Dexamethasone—ankylosing spondylitis	0.00028	0.00246	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000279	0.00245	CcSEcCtD
Cabazitaxel—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000279	0.00245	CcSEcCtD
Cabazitaxel—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000278	0.00245	CcSEcCtD
Cabazitaxel—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000278	0.00245	CcSEcCtD
Cabazitaxel—Anaemia—Prednisone—ankylosing spondylitis	0.000278	0.00244	CcSEcCtD
Cabazitaxel—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000277	0.00244	CcSEcCtD
Cabazitaxel—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000276	0.00243	CcSEcCtD
Cabazitaxel—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000276	0.00243	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000276	0.00243	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000276	0.00243	CcSEcCtD
Cabazitaxel—Tachycardia—Betamethasone—ankylosing spondylitis	0.000275	0.00242	CcSEcCtD
Cabazitaxel—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000275	0.00242	CcSEcCtD
Cabazitaxel—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000273	0.0024	CcSEcCtD
Cabazitaxel—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000273	0.0024	CcSEcCtD
Cabazitaxel—Malaise—Prednisone—ankylosing spondylitis	0.000271	0.00239	CcSEcCtD
Cabazitaxel—Vertigo—Prednisone—ankylosing spondylitis	0.00027	0.00238	CcSEcCtD
Cabazitaxel—Eye disorder—Methotrexate—ankylosing spondylitis	0.00027	0.00237	CcSEcCtD
Cabazitaxel—Tinnitus—Methotrexate—ankylosing spondylitis	0.000269	0.00237	CcSEcCtD
Cabazitaxel—Anorexia—Dexamethasone—ankylosing spondylitis	0.000269	0.00236	CcSEcCtD
Cabazitaxel—Anorexia—Betamethasone—ankylosing spondylitis	0.000269	0.00236	CcSEcCtD
Cabazitaxel—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000268	0.00236	CcSEcCtD
Cabazitaxel—Fatigue—Triamcinolone—ankylosing spondylitis	0.000268	0.00236	CcSEcCtD
Cabazitaxel—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000267	0.00235	CcSEcCtD
Cabazitaxel—Pain—Triamcinolone—ankylosing spondylitis	0.000266	0.00234	CcSEcCtD
Cabazitaxel—Hypotension—Dexamethasone—ankylosing spondylitis	0.000263	0.00232	CcSEcCtD
Cabazitaxel—Hypotension—Betamethasone—ankylosing spondylitis	0.000263	0.00232	CcSEcCtD
Cabazitaxel—Angiopathy—Methotrexate—ankylosing spondylitis	0.000262	0.0023	CcSEcCtD
Cabazitaxel—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000261	0.00229	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00026	0.00229	CcSEcCtD
Cabazitaxel—Hypertension—Prednisone—ankylosing spondylitis	0.00026	0.00228	CcSEcCtD
Cabazitaxel—Chills—Methotrexate—ankylosing spondylitis	0.000259	0.00228	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000257	0.00226	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000257	0.00226	CcSEcCtD
Cabazitaxel—Myalgia—Prednisone—ankylosing spondylitis	0.000256	0.00225	CcSEcCtD
Cabazitaxel—Arthralgia—Prednisone—ankylosing spondylitis	0.000256	0.00225	CcSEcCtD
Cabazitaxel—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000256	0.00225	CcSEcCtD
Cabazitaxel—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000255	0.00225	CcSEcCtD
Cabazitaxel—Anxiety—Prednisone—ankylosing spondylitis	0.000255	0.00224	CcSEcCtD
Cabazitaxel—Alopecia—Methotrexate—ankylosing spondylitis	0.000255	0.00224	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000254	0.00224	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000253	0.00223	CcSEcCtD
Cabazitaxel—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000253	0.00223	CcSEcCtD
Cabazitaxel—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000253	0.00223	CcSEcCtD
Cabazitaxel—Discomfort—Prednisone—ankylosing spondylitis	0.000253	0.00222	CcSEcCtD
Cabazitaxel—Mental disorder—Methotrexate—ankylosing spondylitis	0.000253	0.00222	CcSEcCtD
Cabazitaxel—Malnutrition—Methotrexate—ankylosing spondylitis	0.000251	0.00221	CcSEcCtD
Cabazitaxel—Erythema—Methotrexate—ankylosing spondylitis	0.000251	0.00221	CcSEcCtD
Cabazitaxel—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000249	0.00219	CcSEcCtD
Cabazitaxel—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000248	0.00218	CcSEcCtD
Cabazitaxel—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000248	0.00218	CcSEcCtD
Cabazitaxel—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000246	0.00216	CcSEcCtD
Cabazitaxel—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000246	0.00216	CcSEcCtD
Cabazitaxel—Oedema—Prednisone—ankylosing spondylitis	0.000245	0.00216	CcSEcCtD
Cabazitaxel—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000245	0.00215	CcSEcCtD
Cabazitaxel—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000245	0.00215	CcSEcCtD
Cabazitaxel—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000245	0.00215	CcSEcCtD
Cabazitaxel—Infection—Prednisone—ankylosing spondylitis	0.000244	0.00214	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000243	0.00214	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000243	0.00214	CcSEcCtD
Cabazitaxel—Back pain—Methotrexate—ankylosing spondylitis	0.000243	0.00214	CcSEcCtD
Cabazitaxel—Fatigue—Dexamethasone—ankylosing spondylitis	0.000243	0.00214	CcSEcCtD
Cabazitaxel—Fatigue—Betamethasone—ankylosing spondylitis	0.000243	0.00214	CcSEcCtD
Cabazitaxel—Pain—Betamethasone—ankylosing spondylitis	0.000241	0.00212	CcSEcCtD
Cabazitaxel—Pain—Dexamethasone—ankylosing spondylitis	0.000241	0.00212	CcSEcCtD
Cabazitaxel—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000241	0.00212	CcSEcCtD
Cabazitaxel—Tachycardia—Prednisone—ankylosing spondylitis	0.00024	0.00211	CcSEcCtD
Cabazitaxel—Skin disorder—Prednisone—ankylosing spondylitis	0.000238	0.0021	CcSEcCtD
Cabazitaxel—Anorexia—Prednisone—ankylosing spondylitis	0.000234	0.00206	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000233	0.00205	CcSEcCtD
Cabazitaxel—Anaemia—Methotrexate—ankylosing spondylitis	0.000232	0.00204	CcSEcCtD
Cabazitaxel—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000232	0.00204	CcSEcCtD
Cabazitaxel—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000232	0.00204	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00023	0.00203	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00023	0.00203	CcSEcCtD
Cabazitaxel—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000229	0.00201	CcSEcCtD
Cabazitaxel—TUBB6—Orphan transporters—ANO6—ankylosing spondylitis	0.000229	0.0786	CbGpPWpGaD
Cabazitaxel—TUBB2B—Orphan transporters—ANO6—ankylosing spondylitis	0.000229	0.0786	CbGpPWpGaD
Cabazitaxel—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000228	0.00201	CcSEcCtD
Cabazitaxel—Malaise—Methotrexate—ankylosing spondylitis	0.000227	0.00199	CcSEcCtD
Cabazitaxel—Vertigo—Methotrexate—ankylosing spondylitis	0.000226	0.00199	CcSEcCtD
Cabazitaxel—Leukopenia—Methotrexate—ankylosing spondylitis	0.000225	0.00198	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000224	0.00197	CcSEcCtD
Cabazitaxel—Dizziness—Prednisolone—ankylosing spondylitis	0.000223	0.00196	CcSEcCtD
Cabazitaxel—Asthenia—Triamcinolone—ankylosing spondylitis	0.000223	0.00196	CcSEcCtD
Cabazitaxel—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000223	0.00196	CcSEcCtD
Cabazitaxel—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000223	0.00196	CcSEcCtD
Cabazitaxel—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000223	0.00196	CcSEcCtD
Cabazitaxel—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000223	0.00196	CcSEcCtD
Cabazitaxel—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000222	0.00196	CcSEcCtD
Cabazitaxel—TUBB3—Orphan transporters—ANO6—ankylosing spondylitis	0.000221	0.0759	CbGpPWpGaD
Cabazitaxel—Paraesthesia—Prednisone—ankylosing spondylitis	0.00022	0.00194	CcSEcCtD
Cabazitaxel—Cough—Methotrexate—ankylosing spondylitis	0.000219	0.00193	CcSEcCtD
Cabazitaxel—Dyspepsia—Prednisone—ankylosing spondylitis	0.000216	0.0019	CcSEcCtD
Cabazitaxel—Chest pain—Methotrexate—ankylosing spondylitis	0.000214	0.00188	CcSEcCtD
Cabazitaxel—Myalgia—Methotrexate—ankylosing spondylitis	0.000214	0.00188	CcSEcCtD
Cabazitaxel—Arthralgia—Methotrexate—ankylosing spondylitis	0.000214	0.00188	CcSEcCtD
Cabazitaxel—TUBB2A—Orphan transporters—ANO6—ankylosing spondylitis	0.000214	0.0735	CbGpPWpGaD
Cabazitaxel—Decreased appetite—Prednisone—ankylosing spondylitis	0.000213	0.00188	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000212	0.00187	CcSEcCtD
Cabazitaxel—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000212	0.00186	CcSEcCtD
Cabazitaxel—Fatigue—Prednisone—ankylosing spondylitis	0.000212	0.00186	CcSEcCtD
Cabazitaxel—Headache—Prednisolone—ankylosing spondylitis	0.000212	0.00186	CcSEcCtD
Cabazitaxel—Discomfort—Methotrexate—ankylosing spondylitis	0.000211	0.00186	CcSEcCtD
Cabazitaxel—Constipation—Prednisone—ankylosing spondylitis	0.00021	0.00185	CcSEcCtD
Cabazitaxel—TUBB1—Orphan transporters—ANO6—ankylosing spondylitis	0.000209	0.0719	CbGpPWpGaD
Cabazitaxel—Confusional state—Methotrexate—ankylosing spondylitis	0.000207	0.00182	CcSEcCtD
Cabazitaxel—Dizziness—Triamcinolone—ankylosing spondylitis	0.000205	0.00181	CcSEcCtD
Cabazitaxel—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000205	0.0018	CcSEcCtD
Cabazitaxel—Infection—Methotrexate—ankylosing spondylitis	0.000204	0.00179	CcSEcCtD
Cabazitaxel—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000202	0.00178	CcSEcCtD
Cabazitaxel—Asthenia—Dexamethasone—ankylosing spondylitis	0.000202	0.00178	CcSEcCtD
Cabazitaxel—Asthenia—Betamethasone—ankylosing spondylitis	0.000202	0.00178	CcSEcCtD
Cabazitaxel—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000201	0.00177	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000201	0.00177	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000201	0.00177	CcSEcCtD
Cabazitaxel—Nausea—Prednisolone—ankylosing spondylitis	0.000201	0.00176	CcSEcCtD
Cabazitaxel—Skin disorder—Methotrexate—ankylosing spondylitis	0.000199	0.00175	CcSEcCtD
Cabazitaxel—Vomiting—Triamcinolone—ankylosing spondylitis	0.000197	0.00174	CcSEcCtD
Cabazitaxel—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000197	0.00173	CcSEcCtD
Cabazitaxel—Anorexia—Methotrexate—ankylosing spondylitis	0.000196	0.00172	CcSEcCtD
Cabazitaxel—Headache—Triamcinolone—ankylosing spondylitis	0.000195	0.00171	CcSEcCtD
Cabazitaxel—Headache—Methylprednisolone—ankylosing spondylitis	0.000194	0.00171	CcSEcCtD
Cabazitaxel—Body temperature increased—Prednisone—ankylosing spondylitis	0.000194	0.00171	CcSEcCtD
Cabazitaxel—Abdominal pain—Prednisone—ankylosing spondylitis	0.000194	0.00171	CcSEcCtD
Cabazitaxel—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000193	0.0017	CcSEcCtD
Cabazitaxel—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000193	0.0017	CcSEcCtD
Cabazitaxel—Hypotension—Methotrexate—ankylosing spondylitis	0.000192	0.00169	CcSEcCtD
Cabazitaxel—TUBB4A—Orphan transporters—ANO6—ankylosing spondylitis	0.000188	0.0645	CbGpPWpGaD
Cabazitaxel—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000187	0.00164	CcSEcCtD
Cabazitaxel—Dizziness—Betamethasone—ankylosing spondylitis	0.000186	0.00164	CcSEcCtD
Cabazitaxel—Dizziness—Dexamethasone—ankylosing spondylitis	0.000186	0.00164	CcSEcCtD
Cabazitaxel—Nausea—Triamcinolone—ankylosing spondylitis	0.000184	0.00162	CcSEcCtD
Cabazitaxel—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000184	0.00162	CcSEcCtD
Cabazitaxel—Nausea—Methylprednisolone—ankylosing spondylitis	0.000184	0.00162	CcSEcCtD
Cabazitaxel—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000183	0.00161	CcSEcCtD
Cabazitaxel—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000181	0.00159	CcSEcCtD
Cabazitaxel—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000181	0.00159	CcSEcCtD
Cabazitaxel—Vomiting—Betamethasone—ankylosing spondylitis	0.000179	0.00158	CcSEcCtD
Cabazitaxel—Vomiting—Dexamethasone—ankylosing spondylitis	0.000179	0.00158	CcSEcCtD
Cabazitaxel—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000178	0.00157	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000177	0.00156	CcSEcCtD
Cabazitaxel—Fatigue—Methotrexate—ankylosing spondylitis	0.000177	0.00156	CcSEcCtD
Cabazitaxel—Headache—Dexamethasone—ankylosing spondylitis	0.000177	0.00155	CcSEcCtD
Cabazitaxel—Headache—Betamethasone—ankylosing spondylitis	0.000177	0.00155	CcSEcCtD
Cabazitaxel—Asthenia—Prednisone—ankylosing spondylitis	0.000176	0.00155	CcSEcCtD
Cabazitaxel—Pain—Methotrexate—ankylosing spondylitis	0.000175	0.00154	CcSEcCtD
Cabazitaxel—TUBB4B—Orphan transporters—ANO6—ankylosing spondylitis	0.000172	0.059	CbGpPWpGaD
Cabazitaxel—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000169	0.00149	CcSEcCtD
Cabazitaxel—Diarrhoea—Prednisone—ankylosing spondylitis	0.000168	0.00148	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000168	0.00148	CcSEcCtD
Cabazitaxel—Nausea—Dexamethasone—ankylosing spondylitis	0.000167	0.00147	CcSEcCtD
Cabazitaxel—Nausea—Betamethasone—ankylosing spondylitis	0.000167	0.00147	CcSEcCtD
Cabazitaxel—Dizziness—Prednisone—ankylosing spondylitis	0.000162	0.00143	CcSEcCtD
Cabazitaxel—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000162	0.00143	CcSEcCtD
Cabazitaxel—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000162	0.00143	CcSEcCtD
Cabazitaxel—Vomiting—Prednisone—ankylosing spondylitis	0.000156	0.00137	CcSEcCtD
Cabazitaxel—Headache—Prednisone—ankylosing spondylitis	0.000154	0.00135	CcSEcCtD
Cabazitaxel—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000151	0.00133	CcSEcCtD
Cabazitaxel—Asthenia—Methotrexate—ankylosing spondylitis	0.000147	0.00129	CcSEcCtD
Cabazitaxel—Nausea—Prednisone—ankylosing spondylitis	0.000146	0.00128	CcSEcCtD
Cabazitaxel—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00014	0.00123	CcSEcCtD
Cabazitaxel—Dizziness—Methotrexate—ankylosing spondylitis	0.000136	0.00119	CcSEcCtD
Cabazitaxel—Vomiting—Methotrexate—ankylosing spondylitis	0.00013	0.00115	CcSEcCtD
Cabazitaxel—Headache—Methotrexate—ankylosing spondylitis	0.000128	0.00113	CcSEcCtD
Cabazitaxel—TUBB8—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	0.000124	0.0428	CbGpPWpGaD
Cabazitaxel—Nausea—Methotrexate—ankylosing spondylitis	0.000122	0.00107	CcSEcCtD
Cabazitaxel—TUBA4A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	7.33e-05	0.0252	CbGpPWpGaD
Cabazitaxel—TUBB2B—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	6.29e-05	0.0216	CbGpPWpGaD
Cabazitaxel—TUBB6—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	6.29e-05	0.0216	CbGpPWpGaD
Cabazitaxel—TUBB—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	6.23e-05	0.0214	CbGpPWpGaD
Cabazitaxel—TUBB3—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	6.07e-05	0.0209	CbGpPWpGaD
Cabazitaxel—TUBB2A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	5.88e-05	0.0202	CbGpPWpGaD
Cabazitaxel—TUBB1—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	5.75e-05	0.0198	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	5.58e-05	0.0192	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	5.58e-05	0.0192	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	5.39e-05	0.0185	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	5.22e-05	0.0179	CbGpPWpGaD
Cabazitaxel—TUBB4A—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	5.16e-05	0.0178	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	5.1e-05	0.0175	CbGpPWpGaD
Cabazitaxel—TUBB4B—Pathogenic Escherichia coli infection—TLR4—ankylosing spondylitis	4.72e-05	0.0162	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	4.58e-05	0.0158	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	4.19e-05	0.0144	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	3.79e-05	0.013	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	2.64e-05	0.00908	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	2.54e-05	0.00875	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	2.36e-05	0.0081	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—B3GNT2—ankylosing spondylitis	2.26e-05	0.00779	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—B3GNT2—ankylosing spondylitis	2.26e-05	0.00779	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—B3GNT2—ankylosing spondylitis	2.19e-05	0.00752	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	2.14e-05	0.00737	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	2.12e-05	0.00728	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—B3GNT2—ankylosing spondylitis	2.07e-05	0.00712	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	1.96e-05	0.00674	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—B3GNT2—ankylosing spondylitis	1.86e-05	0.00639	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	1.82e-05	0.00627	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—B3GNT2—ankylosing spondylitis	1.7e-05	0.00585	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	1.34e-05	0.00461	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	1.33e-05	0.00458	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	1.33e-05	0.00458	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	1.27e-05	0.00438	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	1.27e-05	0.00436	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	1.17e-05	0.00404	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—B3GNT2—ankylosing spondylitis	7.92e-06	0.00272	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—B3GNT2—ankylosing spondylitis	5.32e-06	0.00183	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	5.07e-06	0.00174	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—B3GNT2—ankylosing spondylitis	4.93e-06	0.00169	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	3.53e-06	0.00121	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	3.06e-06	0.00105	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	2.66e-06	0.000916	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	2.5e-06	0.000861	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	1.64e-06	0.000564	CbGpPWpGaD
